Biotech & MedTech News
-
Scythian Biosciences Corp. Announces Letter of Intent to Acquire Argentina-Based ABP S.A.
March 12, 2018 (Source) — Scythian takes first step into the global cannabis markets, expanding its business model and…
-
Nova Leap Health Corp. Reports Fourth Quarter and Full Year 2017 Financial Results
March 9, 2018 (Source) — NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or “the Company”), a company focused on…
-
Scythian Biosciences Corp. Announces Results of Special Meeting of Shareholders and Grant of Options and DSUs
March 9, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is…
-
NanoSphere Health Sciences’ Cannabis Brand Now Available in Over 100 Dispensaries
March 7, 2018 (Source) — Evolve Formulas’ Transdermal NanoSerum(TM) Continues to Expand NanoSphere Health Sciences Inc. (CSE: NSHS/ OTC:…
-
Nova Leap Health Corp. Completes Purchase of Massachusetts Home Care Business, Reaches 280,000 Annualized Recurring Service Hours and Provides Update on Integration of Previous Acquisitions
February 26, 2018 (Source) — NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or “the Company”), a company focused on…
-
Nova Leap Health Corp. Closes Brokered and Non-Brokered Private Placements For $1.71 million
February 23, 2018 (Source) — NOVA LEAP HEALTH CORP. (TSXV:NLH) (“Nova Leap” or the “Company”), a company focused on…
-
Scythian Biosciences Corp. Announces Ringing of the Nasdaq Stock Market Closing Bell
February 22, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce…
-
Scythian Biosciences Announces Appointment of Professor Michael Barnes as Chief Medical Officer
February 15, 2018 (Source) — Influential voice in medical cannabis policy in Europe A leading world authority in…
-
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell
February 14, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to…
-
Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor
February 13, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to…
